Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

The Business Development and Commercialization Principal will play a key role in advancing UHN’s research commercialization objectives, including driving efficient execution and timely turnaround of licensing, sponsored research, and other research-related agreements across their assigned portfolio, primarily within the Princess Margaret Cancer Centre. This role requires a dynamic, commercially minded professional with strong academic credentials, demonstrated contract negotiation expertise, and the ability to manage complex stakeholder relationships in fast-paced research and industry environments.

Responsibilities

Proactively engage researchers within the assigned portfolio to understand research priorities and advance commercialization by translating research activities into executable licensing and sponsored research opportunities.
Drive deal flow and contract execution activities in a collaborative team environment, with accountability for timely negotiation and completion of licensing and sponsored research agreements.
Support and lead opportunities for UHN commercialization funds and external ecosystem funding, as required.
Take primary ownership of the assigned portfolio’s contracting activities, including leading the negotiation and turnaround of sponsored research, licensing, and related research agreements such as confidentiality and service agreements.
Coordinate internal stakeholders to reduce cycle times and remove bottlenecks in contract approvals.
Work closely with Licensing & Commercialization, IP Management, Marketing, Operations, Research Legal, and the UHN Foundation to ensure contracts align with institutional policies while enabling rapid deal execution.

Requirements

Minimum of 10 years of relevant business experience or equivalent.
Demonstrated expertise in clinical and translational research environments, with strong working knowledge of Clinical oncology, Oncology broadly.
Experience in the negotiation and completion of research support, licensing and/or partnership deals is required.
Demonstrable and relevant industry and/or investment experience with a strong focus on licensing, sponsored research agreements, and contract execution in complex research environments is required.
Very good knowledge of licensing practice and capacity for autonomously understanding and evaluating detailed legal agreements required.
Experience working in pharmaceutical or biotech business development, technology transfer, venture capital or related environment required.
Good knowledge of patent practice required.
Strong presentation skills required.
Ability to multi-task and prioritize while working under pressure with tight deadlines is required.
Self-starter with demonstrated history of taking initiatives.
Ability and comfort communicating to a range of stakeholders, from researchers to CEOs, from a business and science perspective.
Current UHN employees must have successfully completed their probationary period, have a good employee record along with satisfactory attendance in accordance with UHN's attendance management program, to be eligible for consideration.
All applications must be submitted before the posting close date.
Please ensure you check your email regularly.
A Criminal Record Check may be required of the successful candidate.
Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.

Skills

Contract negotiation expertise
Managing complex stakeholder relationships
Opportunity evaluation
IP protection
Marketing
Licensing
Company formation
Market assessment
IP strategy development
Marketing strategy development
Pharmaceutical partner engagement
Biotechnology partner engagement
Sponsored research agreement negotiation
Licensing agreement negotiation
Term sheet negotiation
Efficient deal structuring
Timely contract closure
Improving efficiency and turnaround time of sponsored research agreements
Improving efficiency and turnaround time of industry licensing
Balancing institutional risk management
Rapidly enabling industry-academic collaborations
Translational research
Commercialization specialization
Clinical oncology
Oncology
Research support deal negotiation
Partnership deal negotiation
Licensing practice
Legal agreement evaluation
Pharmaceutical business development
Biotech business development
Technology transfer
Venture capital
Patent practice
Presentation skills
Launching startup biotech companies
Sourcing seed funding
Sourcing venture capital funding
Divestments
Internet patent searches
Database searches
Multi-tasking
Prioritization
Working under pressure
Working with tight deadlines
Taking initiatives
Communicating with researchers
Communicating with CEOs
Business communication
Science communication

Location

Mars/Hybrid

Work Type

Temporary Full-Time

Experience Level

Minimum of 10 years of relevant business experience or equivalent
Experience launching and leading startup biotech companies (including sourcing seed and venture capital funding and divestments) would be an asset

Education Level

Master’s degree in oncology, immuno-oncology, or a related field, preferably with a translational research and or commercialization specialization or recognized equivalent experience required
PhD and/or MBA highly preferred

Salary/Compensations

$115,730 to $165,730 per annum
CAD 59.35 - CAD 89.03 - hourly

Benefits

Competitive offer packages
Close access to Transit and UHN shuttle service
A flexible work environment
Opportunities for development and promotions within a large organization
Additional perks (multiple corporate discounts including: travel, restaurants, parking, phone plans, auto insurance discounts, on-site gyms, etc.)

About the Company

UHN is Canada’s #1 hospital and the world’s #1 publicly funded hospital.
With 10 sites and more than 44,000 TeamUHN members, UHN consists of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, The Michener Institute of Education and West Park Healthcare Centre.
As Canada's top research hospital, the scope of biomedical research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care.
UHN has the largest hospital-based research program in Canada, with major research in neurosciences, cardiology, transplantation, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine.
UHN is a research hospital affiliated with the University of Toronto.
UHN’s vision is to build A Healthier World and it’s only because of the talented and dedicated people who work here that we are continually bringing that vision closer to reality.
Research at UHN is comprised of two major institutes: Princess Margaret Cancer Centre, and UHN Research Institutes.
Princess Margaret Cancer Centre is where cutting edge oncology research is moved forward every day towards our mission of impacting patients globally.
UHN Research Institutes is internationally recognized for its multidisciplinary biomedical research which encompasses activity across the UHN sites (other than Princess Margaret Cancer Centre) and drives the convergence of care, research, and education across a broad scope of disease fields and disciplines; as such it is a cornerstone of UHN’s innovation ecosystem.
These areas include Krembil Brain Institute, Schroeder Arthritis Institute, Donald K. Johnson Eye Institute, Peter Munk Cardiac Centre, KITE Research Institute, McEwen Stem Cell Institute, Ajmera Transplant Centre, and The Institute for Education Research, as well as research in respiratory health, metabolism and organ function, and health systems and policy.
UHN’s commercialization successes include the Medly cardiac digital health platform, EVLP lung transplant system, Adela Bio Inc., and more.
These companies, first incubated within UHN, are among many others that have collectively injected more than $5 billion into the economy.
among others, which have reshaped patient care and global standards in their respective fields.

Equal Opportunity

UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace.
Requests for accommodation can be made at any stage of the recruitment process.
Applicants need to make their requirements known.